![N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonami...](https://static.cymitquimica.com/cas-image/298628-n-5-45-dihydro-1h-imidazol-2-yl-2-hydroxy-5678-tetrahydronaphthalen-1-yl-methanesulfonamide-hydrobromide.png)
CAS: 107756-30-9 - N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide hydrobromide
Fórmula:C14H20BrN3O3S
InChI:InChI=1/C14H19N3O3S.BrH/c1-21(19,20)17-13-10-3-2-4-11(14-15-7-8-16-14)9(10)5-6-12(13)18;/h5-6,11,17-18H,2-4,7-8H2,1H3,(H,15,16);1H
- Sinónimos:
- Methanesulfonamide, N-[5-(4,5-dihydro-1H-imidazol-2-yl)-5,6,7,8-tetrahydro-2-hydroxy-1-naphthalenyl]-, hydrobromide (1:1)
- N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide hydrobromide (1:1)
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | A 61603 HYDROBROMIDE REF: IN-DA0084ANCAS: 107756-30-9 | - - - | A consultar | Jue 02 Ene 25 |
 | A 61603 REF: TR-A101090CAS: 107756-30-9 | - - - | 10.915,00 € | Lun 10 Feb 25 |
 | A 61603 hydrobromide REF: 3D-BA183359CAS: 107756-30-9 | Min. 95% | A consultar | Mar 11 Feb 25 |
 | A 61603 REF: TM-T21927CAS: 107756-30-9 | - - - | 86,00 €~329,00 € | Mar 18 Feb 25 |
Ref: IN-DA0084AN
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Jueves 2 de Enero de 2025
A 61603
Producto controladoCAS:107756-30-9
Fórmula:
C15H20N2O3S·HBr
Forma y color:
Neat
Peso molecular:
389.308
Ref: TR-A101090
| 1g | 10.915,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Febrero de 2025
A 61603 hydrobromide
CAS:107756-30-9
Please enquire for more information about A 61603 hydrobromide including the price, delivery time and …
Fórmula:
C14H19N3O3S•HBr
Pureza:
Min. 95%
Peso molecular:
390.3 g/mol
Ref: 3D-BA183359
| 1mg | A consultar | ||
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 11 de Febrero de 2025
A 61603
CAS:107756-30-9
Cixutumumab (IMC-A12) is a humanized IgG monoclonal antibody targeting the IGF1R with anticancer activity.
Fórmula:
C14H20BrN3O3S
Forma y color:
Solid
Peso molecular:
390.3
Ref: TM-T21927
| 1mg | 86,00 € | ||
| 5mg | 237,00 € | ||
| 10mg | 329,00 € |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
